Skip to main content
. 2013 Feb;5(1):11–24. doi: 10.1177/1756287212461048

Figure 4.

Figure 4.

Median percentage change from baseline and quartiles in follicle-stimulating hormone in patients switched from leuprolide to degarelix and those continuing degarelix in the extension trial. Reprinted from Crawford et al. [2011] with permission from Elsevier.